These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37523968)

  • 21. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse functions of miR-373 in cancer.
    Wei F; Cao C; Xu X; Wang J
    J Transl Med; 2015 May; 13():162. PubMed ID: 25990556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway.
    Mao J; Hu X; Pang P; Zhou B; Li D; Shan H
    Oncol Rep; 2017 Jul; 38(1):393-401. PubMed ID: 28560434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
    Komoll RM; Hu Q; Olarewaju O; von Döhlen L; Yuan Q; Xie Y; Tsay HC; Daon J; Qin R; Manns MP; Sharma AD; Goga A; Ott M; Balakrishnan A
    J Hepatol; 2021 Jan; 74(1):122-134. PubMed ID: 32738449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
    Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2351-2366. PubMed ID: 30225541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
    Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
    Yue CF; Li LS; Ai L; Deng JK; Guo YM
    Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4.
    Sandbothe M; Buurman R; Reich N; Greiwe L; Vajen B; Gürlevik E; Schäffer V; Eilers M; Kühnel F; Vaquero A; Longerich T; Roessler S; Schirmacher P; Manns MP; Illig T; Schlegelberger B; Skawran B
    J Hepatol; 2017 May; 66(5):1012-1021. PubMed ID: 28088579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling.
    Chen X; Tu J; Liu C; Wang L; Yuan X
    Life Sci; 2022 Nov; 308():120941. PubMed ID: 36087740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression.
    Zhang Y; Xu Z; Wen W; Liu Z; Zhang C; Li M; Hu F; Wei S; Bae S; Zhou J; Liu R; Wang L
    Oncogene; 2022 Jun; 41(23):3186-3196. PubMed ID: 35501464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
    Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
    Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Luan Q; Yang R; Lin L; Li X
    Can J Physiol Pharmacol; 2022 Feb; 100(2):158-166. PubMed ID: 35080988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
    Li X; Zhang Y; Shi Y; Dong G; Liang J; Han Y; Wang X; Zhao Q; Ding J; Wu K; Fan D
    J Cell Mol Med; 2011 Sep; 15(9):1887-95. PubMed ID: 21029372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
    Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
    Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.